Kingston Hospital is the first hospital within South West London to recruit a patient into a new multi-centre, national trial to investigate treatments for COVID-19 patients.
With no treatments for COVID-19 currently approved, the RECOVERY trial, established by the University of Oxford, aims to identify treatments that may be beneficial for adults that are hospitalised with confirmed COVID-19.
Dr Anna Joseph, a Consultant at Kingston Hospital and one of the Principle Investigators for the RECOVERY trial, said: “In these unprecedented times it is more important than ever that we engage with research to find a way to combat COVID-19. The RECOVERY trial is doing just that. We are excited to be a part of this trial and hope that it will be successful in identifying a treatment.”
Jenny Crooks, Head of Research and Innovation at Kingston Hospital, said: “Being a part of this national clinical trial has only been possible thanks to the collaborative effort of our team. Thank you to Dr Anna Joseph and Dr Siva Mahendran for leading on the trial, and to Annette Nicholson, Clinical Trials pharmacist at Kingston Hospital for coordinating the setup so we could get it open rapidly.”
For more information about the national trial, visit www.recoverytrial.net
To find out more about Kingston Hospital, visit www.kingstonhospital.nhs.uk
